Loading…
Attending this event?
avatar for Haritha Vallabhaneni

Haritha Vallabhaneni

FDA, United States
Biological Reviewer, Office of Cellular Therapy and Human Tissue CMC, CBER
Dr. Vallabhaneni is a CMC Reviewer in the Division of Cell Therapy 1, CBER, FDA. She is involved in CMC review of regulatory applications involving cellular therapy products. She has extensive research experience in stem cells previously working on multiple research projects investigating the quality of induced pluripotent stem cells (iPSCs).

My Speakers Sessions

Wednesday, June 19
 

4:30pm PDT

#376: Challenges in Quality Control for Cell and Gene Therapy Development: Regulatory Perspectives and Best Practices Room 6E
 
Share Modal

Share this link via

Or copy link